The transmembrane domain of TACE regulates protein ectodomain shedding

Cell Research

Volumn 17, Issue 12, 2007, Pages 985-998

  Li, Xiaojin ^a   Pérez, Liliana ^a,b,c   Pan, Zui ^a   Fan, Huizhou ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

Ectodomain shedding; L selectin; TACE ADAM17; Transforming growth factor ; Transmembrane domain; Tumor necrosis factor

Indexed keywords

ADAM PROTEIN; GLYCOSYLPHOSPHATIDYLINOSITOL; L SELECTIN; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROLACTIN RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; CELL MEMBRANE; CHO CELL; CRICETULUS; GENETICS; HAMSTER; HUMAN; METABOLISM; MOUSE; MUTATION; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; RABBIT;

ADAM PROTEINS; ANIMALS; CELL MEMBRANE; CHO CELLS; CRICETINAE; CRICETULUS; GLYCOSYLPHOSPHATIDYLINOSITOLS; HUMANS; L-SELECTIN; MICE; MUTATION; PROTEIN STRUCTURE, TERTIARY; RABBITS; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; RECEPTORS, PROLACTIN; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 37149042948     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2007.98     Document Type: Article

References (50)

1. Black RA, Rauch CT, Kozlosky CJ, et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 1997; 385:729-733.
2. Moss ML, Jin SL, Milla ME, et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 1997; 385:733-736.
3. Peschon JJ, Slack JL, Reddy P, et al. An essential role for ectodomain shedding in mammalian development. Science 1998; 282:1281- 1284.
4. Lambert DW, Yarski M, Warner FJ, et al. Tumor necrosis factor-{alpha} convertase (ADAM 17) mediates regulated ectodomain shedding of the severe-acute respiratory syndromecoronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J Biol Chem 2005; 280:30113- 30119.
5. Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL, Lee DC. Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 1990; 61:1121-1135.
6. Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 2001; 11:372-377.
7. Kishimoto TK, Jutila MA, Berg EL, Butcher EC. Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science 1989; 245:1238-1241.
8. Pandiella A, Massague J. Multiple signals activate cleavage of the membrane transforming growth factor-alpha precursor. J Biol Chem 1991; 266:5769-5773.
9. Fan H, Turck CW, Derynck R. Characterization of growth factor-induced serine phosphorylation of tumor necrosis factoralpha converting enzyme and of an alternatively translated polypeptide. J Biol Chem 2003; 278:18617-18627.
10. Fan H, Derynck R. Ectodomain shedding of TGF-alpha and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades. EMBO J 1999; 18:6962-6972.
11. Gechtman Z, Alonso JL, Raab G, Ingber DE, Klagsbrun M. The shedding of membrane-anchored heparin-binding epidermal-like growth factor is regulated by the Raf/mitogen-activated protein kinase cascade and by cell adhesion and spreading. J Biol Chem 1999; 274:28828-28835.
12. Schlondorff J, Becherer JD, Blobel CP. Intracellular maturation and localization of the tumour necrosis factor alpha convertase (TACE). Biochem J 2000; 347(Part 1):131-138.
13. Milla ME, Leesnitzer MA, Moss ML, et al. Specific sequence elements are required for the expression of functional tumor necrosis factor-alpha-converting enzyme (TACE). J Biol Chem 1999; 274:30563-30570.
14. Reddy P, Slack JL, Davis R, et al. Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. J Biol Chem 2000; 275:14608-14614.
15. Diaz-Rodriguez E, Montero JC, Esparis-Ogando A, Yuste L, Pandiella A. Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at Threonine 735: a potential role in regulated shedding. Mol Biol Cell 2002; 13:2031-2044.
16. Li X, Fan H. Loss of ectodomain shedding due to mutations in the metalloprotease and cysteine-rich/disintegrin domains of the tumor necrosis factor-{alpha} converting enzyme (TACE). J Biol Chem 2004; 279:27365- 27375.
17. Arribas J, Coodly L, Vollmer P, Kishimoto TK, Rose-John S, Massague J. Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. J Biol Chem 1996; 271:11376-11382.
18. Gonzales PE, Solomon A, Miller AB, Leesnitzer MA, Sagi I, Milla ME. Inhibition of the tumor necrosis factor-alphaconverting enzyme by its pro domain. J Biol Chem 2004; 279:31638-31645.
19. Lee MH, Verma V, Maskos K, et al. The C-terminal domains of TACE weaken the inhibitory action of N-TIMP-3. FEBS Lett 2002; 520:102-106.
20. Shiang R, Thompson LM, Zhu YZ, et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 1994; 78:335-342.
21. Rousseau F, Bonaventure J, Legeai-Mallet L, et al. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 1994; 371:252-254.
22. Cleverley DZ, Lenard J. The transmembrane domain in viral fusion: essential role for a conserved glycine residue in vesicular stomatitis virus G protein. Proc Natl Acad Sci USA 1998; 95:3425-3430.
23. Constantinescu SN, Keren T, Socolovsky M, Nam H, Henis YI, Lodish HF. Ligand-independent oligomerization of cellsurface erythropoietin receptor is mediated by the transmembrane domain. Proc Natl Acad Sci USA 2001; 98:4379-4384.
24. Itai T, Tanaka M, Nagata S. Processing of tumor necrosis factor by the membrane-bound TNF-alpha-converting enzyme, but not its truncated soluble form. Eur J Biochem 2001; 268:2074-2082.
25. Kahn J, Walcheck B, Migaki GI, Jutila MA, Kishimoto TK. Calmodulin regulates L-selectin adhesion molecule expression and function through a protease-dependent mechanism. Cell 1998; 92:809-818.
26. Rivera A, Chen C-C, Ron N, Dougherty JP, Ron Y. Role of B cells as antigen-presenting cells in vivo revisited: antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations. Int Immunol 2001; 13:1583-1593.
27. Oda K, Cheng J, Saku T, et al. Conversion of secretory proteins into membrane proteins by fusing with a glycosylphosphatidylinositol anchor signal of alkaline phosphatase. Biochem J 1994; 301(Part 2):577-583.
28. Shum L, Turck CW, Derynck R. Cysteines 153 and 154 of transmembrane transforming growth factor-alpha are palmitoylated and mediate cytoplasmic protein association. J Biol Chem 1996; 271:28502-28508.
29. Briley GP, Hissong MA, Chiu ML, Lee DC. The carboxylterminal valine residues of proTGF alpha are required for its efficient maturation and intracellular routing. Mol Biol Cell 1997; 8:1619-1631.
30. Barton GM, Medzhitov R. Retroviral delivery of small interfering RNA into primary cells. Proc Natl Acad Sci USA 2002; 99:14943-14945.
31. Bassi DE, Mahloogi H, Lopez De Cicco R, Klein-Szanto A. Increased furin activity enhances the malignant phenotype of human head and neck cancer cells. Am J Pathol 2003; 162:439-447.
32. Arribas J, Massague J. Transforming growth factor-alpha and beta-amyloid precursor protein share a secretory mechanism. J Cell Biol 1995; 128:433-441.
33. Perez L, Kerrigan JE, Li X, Fan H. Substitution of methionine-435 in tumor necrosis factor-α converting enzyme with leucine, isoleucine and serine inactivate ectodomain shedding activity. Biochem Cell Biol 2007; 85:141-149.
34. Zal T, Gascoigne NR. Photobleaching-corrected FRET efficiency imaging of live cells. Biophys J 2004; 86:3923-3939.
35. Sunnarborg SW, Hinkle CL, Stevenson M, et al. Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J Biol Chem 2002; 277:12838-12845.
36. Doedens JR, Black RA. Stimulation-induced down-regulation of tumor necrosis factor-alpha converting enzyme. J Biol Chem 2000; 275:14598- 14607.
37. Perez L, Kerrigan JE, Li X, Fan H. Substitution of methionine-435 in tumor necrosis factor-α converting enzyme with leucine, isoleucine and serine inactivate ectodomain shedding activity. Biochem Cell Biol 2007; 85:141-149.
38. Ueno S, Lin A, Nikolaeva N, et al. Tryptophan scanning mutagenesis in TM2 of the GABA(A) receptor alpha subunit: effects on channel gating and regulation by ethanol. Br J Pharmacol 2000; 131:296-302.
39. Hasler U, Crambert G, Horisberger JD, Geering K. Structural and functional features of the transmembrane domain of the Na,K-ATPase beta subunit revealed by tryptophan scanning. J Biol Chem 2001; 276:16356-16364.
40. Santiago J, Guzman GR, Torruellas K, Rojas LV, Lasalde-Dominicci JA. Tryptophan scanning mutagenesis in the TM3 domain of the Torpedo californica acetylcholine receptor beta subunit reveals an alpha-helical structure. Biochemistry 2004; 43:10064-10070.
41. Li XA, Everson WV, Smart EJ. Caveolae, lipid rafts, and vascular disease. Trends Cardiovasc Med 2005; 15:92-96.
42. von Tresckow B, Kallen KJ, von Strandmann EP, et al. Depletion of cellular cholesterol and lipid rafts increases shedding of CD30. J Immunol 2004; 172:4324-4331.
43. Zimina EP, Bruckner-Tuderman L, Franzke C-W. Shedding of collagen XVII ectodomain depends on plasma membrane microenvironment. J Biol Chem 2005; 280:34019-34024.
44. Hao M, Mukherjee S, Maxfield FR. Cholesterol depletion induces large scale domain segregation in living cell membranes. Proc Natl Acad Sci USA 2001; 98:13072-13077.
45. Galbiati F, Razani B, Lisanti MP. Emerging themes in lipid rafts and caveolae. Cell 2001; 106:403-411.
46. Edidin M. The state of lipid rafts: from model membranes to cells. Annu Rev Biophys Biomol Struct 2003; 32:257-283.
47. Ceppi P, Colombo S, Francolini M, Raimondo F, Borgese N, Masserini M. Two domain-anchored protein variants, differing in transmembrane domain length and intracellular sorting, interact differently with lipids. Proc Natl Acad Sci USA 2005; 102:16269-16274.
48. Yelamanchili SV, Reisinger C, Becher A, et al. The C-terminal transmembrane region of synaptobrevin binds synaptophysin from adult synaptic vesicles. Eur J Cell Biol 2005; 84:467-475.
49. Greie JC, Heitkamp T, Altendorf K. The transmembrane domain of subunit b of the Escherichia coli F1F(O) ATP synthase is sufficient for H(+)-translocating activity together with subunits a and c. Eur J Biochem 2004; 271:3036-3042.
50. Doedens JR, Mahimkar RM, Black RA. TACE/ADAM-17 enzymatic activity is increased in response to cellular stimulation. Biochem Biophys Res Commun 2003; 308:331-338.